The new SPAC intends to focus its search on the intersection of the healthcare and technology industries, specifically within the biotechnology and pharmaceutical sectors. Genesis Unicorn Capital is led by Chief Executive Officer Adeoye Olukotun, President and Chief Financial Officer Samuel Liu, Chief Scientific Officer Niel Starksen, Chief Operating Officer Juan Fernandez Pascual, and Co-Chairmen Grainne Coen and Ernest Fong.
Total SPAC deal count for 2022 year-to-date is now 37. This offering is expected to close on Thursday, February 17.
EF Hutton, division of Benchmark Investments, LLC, is acting as the sole book running manager for the offering. Becker & Poliakoff LLP is serving as Issuer’s Counsel with Hogan Lovells US LLP serving as Underwriter’s Counsel. MaloneBailey, LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.